These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 17531605

  • 21. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.
    Lockhat FB, Emembolu JO, Konje JC.
    Hum Reprod; 2005 Mar; 20(3):789-93. PubMed ID: 15608040
    [Abstract] [Full Text] [Related]

  • 22. The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis.
    Yucel N, Baskent E, Karamustafaoglu Balci B, Goynumer G.
    Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):560-563. PubMed ID: 29359457
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D, Janssens D, Vrijens M, Weyers S.
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M, Odlind V.
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [Abstract] [Full Text] [Related]

  • 28. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, Gupta JK.
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [Abstract] [Full Text] [Related]

  • 29. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
    Abou-Setta AM, Al-Inany HG, Farquhar CM.
    Cochrane Database Syst Rev; 2006 Oct 18; (4):CD005072. PubMed ID: 17054236
    [Abstract] [Full Text] [Related]

  • 30. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
    Zheng J, Xia E, Li TC, Sun X.
    J Reprod Med; 2013 Oct 18; 58(7-8):285-90. PubMed ID: 23947077
    [Abstract] [Full Text] [Related]

  • 31. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS, Kim ML, Song T, Yun BS, Kim MK, Jun HS, Seong SJ.
    Taiwan J Obstet Gynecol; 2015 Aug 18; 54(4):412-5. PubMed ID: 26384061
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis.
    Choi YS, Cho S, Lim KJ, Jeon YE, Yang HI, Lee KE, Heena K, Seo SK, Kim HY, Lee BS.
    Growth Factors; 2010 Dec 18; 28(6):452-60. PubMed ID: 20854189
    [Abstract] [Full Text] [Related]

  • 35. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P, Paavonen J, Heikinheimo O.
    Contraception; 2007 Jan 18; 75(1):37-9. PubMed ID: 17161122
    [Abstract] [Full Text] [Related]

  • 36. Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
    Margatho D, Carvalho NM, Bahamondes L.
    Eur J Contracept Reprod Health Care; 2020 Apr 18; 25(2):133-140. PubMed ID: 32069126
    [Abstract] [Full Text] [Related]

  • 37. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.
    Heliövaara-Peippo S, Halmesmäki K, Hurskainen R, Teperi J, Grenman S, Kivelä A, Kujansuu E, Tuppurainen M, Vuorma S, Yliskoski M, Paavonen J.
    Acta Obstet Gynecol Scand; 2009 Apr 18; 88(12):1389-96. PubMed ID: 19878089
    [Abstract] [Full Text] [Related]

  • 38. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis.
    Lan S, Ling L, Jianhong Z, Xijing J, Lihui W.
    J Int Med Res; 2013 Jun 18; 41(3):548-58. PubMed ID: 23660087
    [Abstract] [Full Text] [Related]

  • 39. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
    Fong YF, Singh K.
    Contraception; 1999 Sep 18; 60(3):173-5. PubMed ID: 10640162
    [Abstract] [Full Text] [Related]

  • 40. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS, Reardon B, Arepally G.
    Fertil Steril; 2008 Sep 18; 90(3):673-7. PubMed ID: 18001734
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.